UditNarainVermaMD

PubMed

• 2 citations
  Disparities in Characteristics, Access to Care, and Oncologic Outcomes in Young-Onset Colorectal Cancer at a Safety-Net Hospital.
  Benjamin D Fangman, Suleyman Yasin Goksu, Nivan Chowattukunnel, Muhammad Shaalan Beg, Nina N. Sanford, Aravind Sanjeevaiah, John Cox, Michael R. Folkert, Todd A. Aguil...> ;JCO Oncology Practice. 2021 Jan 11
• 3 citations
  Racial/Ethnic Disparities and Survival Characteristics in Non-Pancreatic Gastrointestinal Tract Neuroendocrine Tumors.
  Suleyman Yasin Goksu, Muhammet Ozer, Muhammad Shaalan Beg, Nina N. Sanford, Chul Ahn, Benjamin D Fangman, Busra N Bacik Goksu, Udit Verma, Aravind Sanjeevaiah, David H...> ;Cancers. 2020 Oct 15
• When Phenotype Does Not Match Genotype-The Importance of Returning to the Raw Data.
  Megan B. Wachsmann, Udit Verma, Yull Edwin Arriaga, Suntrea T.G. Hammer, Dwight H Oliver> ;The Journal of Applied Laboratory Medicine. 2019 Nov 1
• 162 citations
  Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution.
  Abdel Nasser Hosein, Huocong Huang, Zhaoning Wang, Kamalpreet Parmar, Wenting Du, Jonathan Huang, Anirban Maitra, Eric N. Olson, Udit Verma, Rolf A. Brekken> ;JCI Insight. 2019 Aug 22
• 83 citations
  Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN Study
  Eric Van Cutsem, Erika Martinelli, Stefano Cascinu, Alberto Sobrero, Maria Banzi, Jean Francois Seitz, Carlo Barone, Marc Ychou, Marc Peeters, Baruch Brenner, Ralf Hof...> ;The Oncologist. 2019 Feb 1
• 34 citations
  Blocking Monocytic Myeloid-Derived Suppressor Cell Function via Anti-DC-HIL/GPNMB Antibody Restores the In Vitro Integrity of T Cells from Cancer Patients.
  Masato Kobayashi, Jin Sung Chung, Muhammad Shaalan Beg, Yull Edwin Arriaga, Udit Verma, Kevin D. Courtney, John C. Mansour, Barbara Haley, Saad A. Khan, Yutaka Horiuch...> ;Clinical Cancer Research. 2019 Jan 15
• 2 citations
  Fasting and Glucose-Stimulated Changes in Plasma Glucagon in Pancreatic Cancer: Potential Biomarkers for Detection?
  Jennifer H. Stern, Yull Edwin Arriaga, Arjun Gupta, Udit Verma, Sirisha Karri, Samira Syed, Leticia Khosama, John C. Mansour, Jeffrey Meyer, Philipp E. Scherer, Muhamm...> ;Pancreas. 2019 Jan 1
• 26 citations
  A phase III trial comparing oral S-1/cisplatin and intravenous 5-fluorouracil/cisplatin in patients with untreated diffuse gastric cancer.
  Jaffer A. Ajani, M. Abramov, Igor Bondarenko, Yaroslav Shparyk, Vera Gorbunova, A. Hontsa, N. Otchenash, Maria Alsina, Sergey Lazarev, Jaime Feliu, Anneli Elme, V. Esk...> ;Annals of Oncology. 2017 Sep 1
• 5 citations
  A Phase I Clinical Trial of the Phosphatidylserine-targeting Antibody Bavituximab in Combination With Radiation Therapy and Capecitabine in the Preoperative Treatment ...
  Jeffrey J Meyer, Yull Edwin Arriaga, Joselin L. Anandam, Sirisha Karri, Samira Syed, Udit Verma, Abier Abdelnaby, Grace Raja, Ying Dong, Muhammad Shaalan Beg, Glen C. ...> ;American Journal of Clinical Oncology. 2017 Jul 1
• 75 citations
  A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Simtuzumab in Combination with FOLFIRI for the Second-Line Treatment of Metastatic KRAS Mutant Colore...
  J. Randolph Hecht, Al B. Benson, Dmitry Vyushkov, Yingsi Yang, Johanna C. Bendell, Udit Verma> ;The Oncologist. 2017 Mar 1
• 33 citations
  Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, O...
  Jerome C. Landry, Yang Feng, Roshan S. Prabhu, Steven J. Cohen, Charles A. Staley, Richard Whittington, Elin R. Sigurdson, Halla Sayed Nimeiri, Udit Verma, Al B. Benson> ;The Oncologist. 2015 Jun 1
• 41 citations
  Phase 2 study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5-fluorouracil, leucovorin, ox...
  Jerome C. Landry, Yang Feng, Steven J. Cohen, Charles A. Staley, Richard Whittington, Elin R. Sigurdson, Halla Sayed Nimeiri, Udit Verma, Roshan S. Prabhu, Al B. Benson> ;Cancer. 2013 Apr 15
• 12 citations
  Shorter bevacizumab infusions do not increase the incidence of proteinuria and hypertension
  Sachin R Shah, S. M. Gressett Ussery, Jonathan E. Dowell, E. Marley, J. Liticker, Yull Edwin Arriaga, Udit Verma> ;Annals of Oncology. 2013 Apr 1
• 18 citations
  Cells lacking IKKα show nuclear cyclin D1 overexpression and a neoplastic phenotype: role of IKKα as a tumor suppressor.
  Youn Tae Kwak, Sofyan M. Radaideh, Lianghao Ding, Rui Li, Eugene P. Frenkel, Michael D. Story, Luc Girard, John D. Minna, Udit Verma> ;Molecular Cancer Research. 2011 Mar 1
• 34 citations
  An open-label clinical trial evaluating safety and pharmacokinetics of two dosing schedules of panitumumab in patients with solid tumors
  Joe Stephenson, Charles Gregory, Howard A. Burris, Timothy G. Larson, Udit Verma, Allen Lee Cohn, Jeffrey Crawford, Roger B. Cohen, Julie C. Martin, Peggy Lum, Xinqun ...> ;Clinical Colorectal Cancer. 2009 Jan 1
• 23 citations
  Soluble and insoluble nickel compounds exert a differential inhibitory effect on cell growth through IKKα‐dependent cyclin D1 down‐regulation
  Weiming Ouyang, Dongyun Zhang, Jingxia Li, Udit Verma, Max Costa, Chuanshu Huang> ;Journal of Cellular Physiology. 2009 Jan 1
• 2 citations
  Phase i dose escalation study with irinotecan, capecitabine, epirubicin, and granulocyte colony-stimulating factor support for patients with solid malignancies
  Udit Verma, Hia T. Tran, Denise Tavana, Noelle S. Williams, Eugene P. Frenkel> ;American Journal of Clinical Oncology. 2008 Jun 1
• 20 citations
  Efficacy of sequential treatment of HCT116 colon cancer monolayers and xenografts with docetaxel, flavopiridol, and 5-fluorouracil
  Jun Guo, An-wu Zhou, Yu-cai Fu, Udit Verma, Debu Tripathy, Eugene P. Frenkel> ;Acta Pharmacologica Sinica. 2006 Oct 1
• 54 citations
  IκB Kinase α Regulates Subcellular Distribution and Turnover of Cyclin D1 by Phosphorylation
  Youn Tae Kwak, Rui Li, Debu Tripathy, Eugene P. Frenkel, Udit Verma> ;The Journal of Biological Chemistry. 2005 Oct 7
• 76 citations
  Enhanced chemosensitivity to irinotecan by RNA interference-mediated down-regulation of the nuclear factor-κB p65 subunit
  Jun Guo, Udit Verma, Richard B. Gaynor, Eugene P. Frenkel> ;Clinical Cancer Research. 2004 May 15
• 67 citations
  Nuclear Role of IκB Kinase-γ/NF-κB Essential Modulator (IKKγ/NEMO) in NF-κB-dependent Gene Expression
  Udit Verma, Yumi Yamamoto, Shashi Prajapati, Richard B. Gaynor> ;The Journal of Biological Chemistry. 2004 Jan 30
• 466 citations
  Histone H3 phosphorylation by IKK-α is critical for cytokine-induced gene expression
  Yumi Yamamoto, Udit Verma, Shashi Prajapati, Youn-Tae Kwak, Richard B. Gaynor> ;Nature. 2003 Jun 5
• 253 citations
  Small Interfering RNAs Directed against β-Catenin Inhibit the in Vitro and in Vivo Growth of Colon Cancer Cells
  Udit Verma, Rama M. Surabhi, Aurelia Schmaltieg, Richard B. Gaynor> ;Clinical Cancer Research. 2003 Apr 1
• 155 citations
  Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference.
  Noelle S. Williams, Richard B. Gaynor, Shane Scoggin, Udit Verma, Tunc Gokaslan, Clifford Simmang, Jason B. Fleming, Denise Tavana, Eugene P. Frenkel> ;Clinical Cancer Research. 2003 Mar 1
• 133 citations
  IKKα regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf
  Chris Albanese, Kongming Wu, Mark D'Amico, Christy Rothwell Jarrett, David Joyce, Julian Hughes, James Hulit, Toshiyuki Sakamaki, Maofu Fu, Avri Ben-Ze'ev, Jacqueline ...> ;Molecular Biology of the Cell. 2003 Feb 1
• Join now to see all